Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 908.35
+3.00 (0.33%)
Nov 28, 2025, 3:29 PM IST
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 178.32 billion as of November 28, 2025. Its market cap has decreased by -15.99% in one year.
Market Cap
178.32B
Enterprise Value
191.75B
Revenue
70.83B
Ranking
n/a
PE Ratio
28.09
Stock Price
908.35
Market Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 178.32B, an increase of 1,881.00%. That is a compound annual growth rate of 23.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 27, 2025 | 177.96B | -15.09% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | 203.20B | 88.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.34T |
| Divi's Laboratories | 1.72T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.05T |
| Zydus Lifesciences | 943.09B |
| Mankind Pharma | 928.42B |
| Aurobindo Pharma | 717.75B |
| Fortis Healthcare | 696.15B |